Icu Medical [ICUI] vs Stevanato [STVN] Detailed Stock Comparison
Icu Medical
NASDAQ
Loading...
Stevanato
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 19 vital metrics comparison: Icu Medical wins in 9 metrics, Stevanato wins in 10 metrics, with 0 ties. Stevanato appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Icu Medical | Stevanato | Better |
|---|---|---|---|
| P/E Ratio (TTM) | -26.49 | 46.19 | Icu Medical |
| Price-to-Book Ratio | 1.58 | 4.81 | Icu Medical |
| Debt-to-Equity Ratio | 80.57 | 27.86 | Stevanato |
| PEG Ratio | 18.65 | 41.57 | Icu Medical |
| EV/EBITDA | 13.27 | 29.52 | Icu Medical |
| Profit Margin (TTM) | -3.87% | 11.16% | Stevanato |
| Operating Margin (TTM) | 4.89% | 13.97% | Stevanato |
| EBITDA Margin (TTM) | 4.89% | 13.97% | Stevanato |
| Return on Equity | -4.62% | 9.14% | Stevanato |
| Return on Assets (TTM) | 1.79% | 4.88% | Stevanato |
| Free Cash Flow (TTM) | $113.83M | $-157.80M | Icu Medical |
| 1-Year Return | -0.34% | 29.83% | Stevanato |
| Price-to-Sales Ratio (TTM) | 1.30 | 6.05 | Icu Medical |
| Enterprise Value | $4.44B | $8.26B | Stevanato |
| EV/Revenue Ratio | 1.84 | 6.40 | Icu Medical |
| Gross Profit Margin (TTM) | 34.75% | 27.24% | Icu Medical |
| Revenue per Share (TTM) | $99 | $4 | Icu Medical |
| Earnings per Share (Diluted) | $-3.82 | $0.54 | Stevanato |
| Beta (Stock Volatility) | 0.87 | 0.56 | Stevanato |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Icu Medical vs Stevanato Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Icu Medical | -0.99% | -2.74% | -5.05% | -8.14% | -24.37% | -20.58% |
| Stevanato | -1.31% | -1.85% | 2.09% | 19.56% | 13.73% | 11.44% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Icu Medical | -0.34% | -30.15% | -29.39% | 25.86% | 248.24% | 316.71% |
| Stevanato | 29.83% | 36.51% | 26.79% | 26.79% | 26.79% | 26.79% |
Performance & Financial Health Analysis: Icu Medical vs Stevanato
| Metric | ICUI | STVN |
|---|---|---|
| Market Information | ||
| Market Cap | $3.13B | $6.81B |
| Market Cap Category | Mid cap | Mid cap |
| 10 Day Avg. Volume | 164,567 | 385,470 |
| 90 Day Avg. Volume | 205,399 | 310,123 |
| Last Close | $125.47 | $24.94 |
| 52 Week Range | $117.92 - $196.26 | $17.12 - $28.00 |
| % from 52W High | -36.07% | -10.93% |
| All-Time High | $321.70 (Aug 06, 2018) | $36.30 (Aug 07, 2023) |
| % from All-Time High | -61.00% | -31.29% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.07% | 0.09% |
| Quarterly Earnings Growth | 0.07% | 0.41% |
| Financial Health | ||
| Profit Margin (TTM) | -0.04% | 0.11% |
| Operating Margin (TTM) | 0.05% | 0.14% |
| Return on Equity (TTM) | -0.05% | 0.09% |
| Debt to Equity (MRQ) | 80.57 | 27.86 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $80.76 | $5.19 |
| Cash per Share (MRQ) | $12.11 | $0.33 |
| Operating Cash Flow (TTM) | $209.57M | $211.09M |
| Levered Free Cash Flow (TTM) | $77.29M | $-130,160,130 |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | N/A |
| Last 12-Month Dividend | N/A | $0.00 |
Valuation & Enterprise Metrics Analysis: Icu Medical vs Stevanato
| Metric | ICUI | STVN |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | -26.49 | 46.19 |
| Forward P/E | 18.65 | 41.57 |
| PEG Ratio | 18.65 | 41.57 |
| Price to Sales (TTM) | 1.30 | 6.05 |
| Price to Book (MRQ) | 1.58 | 4.81 |
| Market Capitalization | ||
| Market Capitalization | $3.13B | $6.81B |
| Enterprise Value | $4.44B | $8.26B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 1.84 | 6.40 |
| Enterprise to EBITDA | 13.27 | 29.52 |
| Risk & Other Metrics | ||
| Beta | 0.87 | 0.56 |
| Book Value per Share (MRQ) | $80.76 | $5.19 |
Financial Statements Comparison: Icu Medical vs Stevanato
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | ICUI | STVN |
|---|---|---|
| Revenue/Sales | $604.70M | $256.60M |
| Cost of Goods Sold | $394.59M | $186.71M |
| Gross Profit | $210.11M | $69.89M |
| Research & Development | $23.29M | $5.93M |
| Operating Income (EBIT) | $29.59M | $34.63M |
| EBITDA | $82.47M | $55.55M |
| Pre-Tax Income | $-10.91M | $35.11M |
| Income Tax | $4.57M | $8.60M |
| Net Income (Profit) | $-15.48M | $26.51M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | ICUI | STVN |
|---|---|---|
| Cash & Equivalents | $289.70M | $90.72M |
| Total Current Assets | $1.42B | $845.47M |
| Total Current Liabilities | $549.02M | $463.26M |
| Long-Term Debt | $1.54B | $312.73M |
| Total Shareholders Equity | $1.99B | $1.42B |
| Retained Earnings | $674.68M | $890.85M |
| Property, Plant & Equipment | $466.20M | $110.62M |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | ICUI | STVN |
|---|---|---|
| Operating Cash Flow | $90.80M | $100.69M |
| Capital Expenditures | $-14.62M | $-69.33M |
| Free Cash Flow | $34.47M | $28.05M |
| Debt Repayment | $-48.08M | $-55.75M |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | ICUI | STVN |
|---|---|---|
| Shares Short | 1.18M | 2.17M |
| Short Ratio | 5.25 | 7.35 |
| Short % of Float | 0.06% | 0.04% |
| Average Daily Volume (10 Day) | 164,567 | 385,470 |
| Average Daily Volume (90 Day) | 205,399 | 310,123 |
| Shares Outstanding | 24.52M | 272.90M |
| Float Shares | 23.85M | 48.81M |
| % Held by Insiders | 0.03% | 0.02% |
| % Held by Institutions | 1.01% | 1.13% |
Dividend Analysis & Yield Comparison: Icu Medical vs Stevanato
| Metric | ICUI | STVN |
|---|---|---|
| Last 12-Month Dividend | N/A | $0.00 |
| Last 12-Month Dividend Yield | N/A | N/A |
| 3-Year Avg Annual Dividend | N/A | $0.04 |
| 3-Year Avg Dividend Yield | N/A | 0.26% |
| 3-Year Total Dividends | N/A | $0.12 |
| Ex-Dividend Date | N/A | Jun 04, 2024 |